These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37112704)

  • 1. A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments.
    Siddiqui AJ; Bhardwaj J; Saxena J; Jahan S; Snoussi M; Bardakci F; Badraoui R; Adnan M
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The March Toward Malaria Vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A landscape review of malaria vaccine candidates in the pipeline.
    Tajudeen YA; Oladipo HJ; Yusuff SI; Abimbola SO; Abdulkadir M; Oladunjoye IO; Omotosho AO; Egbewande OM; Shittu HD; Yusuf RO; Ogundipe O; Muili AO; Afolabi AO; Dahesh SMA; Gameil MAM; El-Sherbini MS
    Trop Dis Travel Med Vaccines; 2024 Aug; 10(1):19. PubMed ID: 39085983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
    Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
    Vaccine; 2014 Mar; 32(11):1296-303. PubMed ID: 24397898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.
    Collins KA; Brod F; Snaith R; Ulaszewska M; Longley RJ; Salman AM; Gilbert SC; Spencer AJ; Franco D; Ballou WR; Hill AVS
    Sci Rep; 2021 May; 11(1):10792. PubMed ID: 34031479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects.
    El-Moamly AA; El-Sweify MA
    Trop Med Health; 2023 May; 51(1):29. PubMed ID: 37198702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The world's first malaria vaccine: Hope and challenge].
    Zhang YL; Pan WQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Jan; 33(6):560-562. PubMed ID: 35128884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.
    Datoo MS; Natama HM; Somé A; Bellamy D; Traoré O; Rouamba T; Tahita MC; Ido NFA; Yameogo P; Valia D; Millogo A; Ouedraogo F; Soma R; Sawadogo S; Sorgho F; Derra K; Rouamba E; Ramos-Lopez F; Cairns M; Provstgaard-Morys S; Aboagye J; Lawrie A; Roberts R; Valéa I; Sorgho H; Williams N; Glenn G; Fries L; Reimer J; Ewer KJ; Shaligram U; Hill AVS; Tinto H
    Lancet Infect Dis; 2022 Dec; 22(12):1728-1736. PubMed ID: 36087586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards next-generation treatment options to combat Plasmodium falciparum malaria.
    Okombo J; Fidock DA
    Nat Rev Microbiol; 2024 Oct; ():. PubMed ID: 39367132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
    Waitumbi JN; Anyona SB; Hunja CW; Kifude CM; Polhemus ME; Walsh DS; Ockenhouse CF; Heppner DG; Leach A; Lievens M; Ballou WR; Cohen JD; Sutherland CJ
    PLoS One; 2009 Nov; 4(11):e7849. PubMed ID: 19924281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of malaria vaccines-state of the art].
    Metzger WG; Sulyok Z; Theurer A; Köhler C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):45-55. PubMed ID: 31828371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosoma egg-induced liver pathology resolution by Sm-p80-based schistosomiasis vaccine in baboons.
    Le L; Molehin AJ; Nash S; Sennoune SR; Ahmad G; Torben W; Zhang W; Siddiqui AA
    Pathology; 2018 Jun; 50(4):442-449. PubMed ID: 29739616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons.
    Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
    J Infect Dis; 2014 Jun; 209(12):1929-40. PubMed ID: 24436452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria Vaccines: Moving Forward After Encouraging First Steps.
    Tran TM; Portugal S; Draper SJ; Crompton PD
    Curr Trop Med Rep; 2015 Mar; 2(1):1-3. PubMed ID: 25995985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress on vaccines against parasites.
    Engers HD; Bergquist R; Modabber F
    Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of vaccines against human parasitic diseases: tools, current status and perspectives.
    Abath FG
    Expert Opin Investig Drugs; 2000 Feb; 9(2):301-10. PubMed ID: 11060678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
    Olotu A; Moris P; Mwacharo J; Vekemans J; Kimani D; Janssens M; Kai O; Jongert E; Lievens M; Leach A; Villafana T; Savarese B; Marsh K; Cohen J; Bejon P
    PLoS One; 2011; 6(10):e25786. PubMed ID: 21998698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan.
    Mahmoudi S; Keshavarz H
    Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.